APO-ENTECAVIR is a brand name for Entecavir, supplied as a tablet. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: AND CLINICAL USE ................................................................................................ 3 CONTRAINDICATIONS.................................................................................................................. 3 WARNINGS AND PRECAUTIONS…
Verbatim from this product's HC label. Tap a section to expand.
5 mg once daily. 5 mg tablets) once daily. APO-ENTECAVIR should be administered on an empty stomach (at least 2 hours after a meal and at least 2 hours before the next meal). Renal Impairment In patients with renal impairment, the apparent oral clearance of entecavir decreased as creatinine clearance decreased.
Dosage adjustment is recommended for patients with creatinine clearance <50 mL/min, including patients on hemodialysis or CAPD (continuous ambulatory peritoneal dialysis), as shown in Table 4. 5 mg every 7 days 1 mg every 7 days a On hemodialysis days, administer after hemodialysis.
Hepatic Impairment No dosage adjustment is necessary for patients with hepatic impairment. Duration of Therapy The optimal duration of treatment with entecavir for patients with chronic hepatitis B infection and the relationship between treatment and long-term outcomes such as cirrhosis and hepatocellular carcinoma are unknown.
APO-ENTECAVIR (Entecavir Tablets) Page 13 of
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Entecavir in Canada.
Know a brand we are missing in Canada? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.